COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Aston Bay Receives C$1.38 Million Initial Royalty Payment for the Storm Copper Project, Canada
Aston Bay Holdings Ltd. receives first payment of C$3.46 million under royalty package for Storm Copper Project with no use of proceeds restriction from American West Metals Limited and Taurus Mining Royalty Fund L.P -
-
COMMUNIQUÉ DE PRESSE
USPA Global Announces Strategic Broadcast Association With Star Sports, Reaching Millions of Polo Sports Fans Across India
USPA Global partners with Star Sports for an exclusive broadcasting agreement to bring polo content to Indian viewers. The collaboration aims to promote the sport globally -
COMMUNIQUÉ DE PRESSE
Blackbridge Investment Group (BIG) Announces Innovative Revenue-Based Financing Solution
Blackbridge Investment Group introduces an innovative revenue-based financing solution for small and mid-size companies, offering flexible growth capital without equity dilution. Their tech-driven approach provides faster funding decisions -
COMMUNIQUÉ DE PRESSE
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Quantum BioPharma files $700M lawsuit against CIBC, RBC for market manipulation schemes. Press release details legal action and evidence. Law firms Christian Attar and Freedman Normand Friedland LLP to take the case on a contingency basis -
COMMUNIQUÉ DE PRESSE
Mako Mining Announces Q3 2024 Operational Results for the San Albino Mine and Update on the Eagle Mountain Gold Project
Mako Mining Corp. reports Q3 2024 production results for San Albino gold mine in Nicaragua and updates on Eagle Mountain gold project in Guyana. Stockpile estimated at 135,496 tonnes of 2.49 g/t Au -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Salzgitter Aktiengesellschaft: Guidance adjusted for the financial year 2024; non-recurrent items with effect on earnings guidance lay foundation for future-proof positioning
Salzgitter Aktiengesellschaft adjusts guidance for 2024 due to non-recurrent items affecting earnings, implementing measures for future-proofing -
-
COMMUNIQUÉ DE PRESSE
Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
Immunic announces positive outcome of interim analysis of Phase 3 ENSURE Program for vidofludimus calcium in RMS. Trials recommended to continue unchanged till 2026
